International Journal of Pharmaceutical Investigation
Volume 16, Issue 3
2026 · pp. 770–1201 · 48 articles
- Volume
- 16
- Issue
- 3
- Year
- 2026
- Published
- 11 Jun 2026
- Pages
- 770–1201
- Articles
- 48
- Sections
- 3
- ISSN
- 2230-9713
- Journal
- IJPI
In this issue
41–48 of 48Original Article(continued)
Original ArticlePublished: 11 Jun 2026
Vijay Sharma, Maneesh Kumar Singh, Gurvinder Pal Singh, Gyanendra Kumar Sharma, Navneet Verma
pp. 1123-1134 · DOI: 10.5530/ijpi.20260567Vol. 16, Issue 3 (2026)Aim/Background: The aim of the present study was to develop and optimize a dosage form of L-arginine as a nanoparticle for prolonged release. The Quality by Design (QbD) approach was employed to develop and optimize the …
Original ArticlePublished: 11 Jun 2026
Sreeraj Kandoth, Narayana Charyulu Rompicherla, Sarath Chandran Chadrashekar Shenoy, Uday Venkat Mateti, Juno Jerold Joel, Sarin Shyamala Mohanan
pp. 1135-1142 · DOI: 10.5530/ijpi.20260205Vol. 16, Issue 3 (2026)Background: Topical Corticosteroids (TCs) are widely prescribed for managing dermatological conditions due to their efficacy in reducing inflammation and related symptoms. However, misuse, suboptimal prescribing practice…
Original ArticlePublished: 11 Jun 2026
Ghadeer Bukhari
pp. 1143-1151 · DOI: 10.5530/ijpi.20260265Vol. 16, Issue 3 (2026)Background: The NS5 protein in Dengue Virus Serotype-1 (DENV-1) is a multifunctional enzyme that is crucial for the virus to reproduce and evade the immune system. One important part of NS5 is the methyltransferase (MTas…
Original ArticlePublished: 11 Jun 2026
Rametrika Saha, Veeranagoud Biradar, Spoorti Konkani, Mandati Santhosh Reddy, Bhavana Doshi
pp. 1152-1157 · DOI: 10.5530/ijpi.20260228Vol. 16, Issue 3 (2026)Background: Pemphigus vulgaris (PV) is a severe autoimmune blistering disorder traditionally managed with corticosteroids, which are associated with significant adverse effects; as a result, alternative therapies such as…
Original ArticlePublished: 11 Jun 2026
Mandati Santhosh Reddy, Madiwalayya Shivakantayya Ganachari
pp. 1170-1175 · DOI: 10.5530/ijpi.20260262Vol. 16, Issue 3 (2026)Background: Antiplatelet therapy is central to managing Coronary Artery Disease (CAD), but benefits are offset by Adverse Drug Reactions (ADRs), particularly bleeding. Objectives: To compare the causality, severity, and …
Original ArticlePublished: 11 Jun 2026
Nawal Helmi, Hanadi Mohammed Baeissa, Israa Jameel Hakeem, Dalia Muhammed Alammari
pp. 1176-1182 · DOI: 10.5530/ijpi.20260009Vol. 16, Issue 3 (2026)Background: High-touch surfaces in healthcare settings can act as reservoirs for microbial transmission, underscoring the need for durable antimicrobial surface interventions that remain effective under realistic use con…
Original ArticlePublished: 11 Jun 2026
Israa Jameel Hakeem, Shahnaz Haque, Misbahuddin Rafeeq, Mohammad Azhar Kamal, Tahani Bakhsh, Abdulrahman Almutairi, Rashed Ahmed Alniwaider, Ali Bin Thani, Qamre Alam
pp. 1183-1193 · DOI: 10.5530/ijpi.20260022Vol. 16, Issue 3 (2026)Background: Cyclin-Dependent Kinase is a member of cell cycle regulatory proteins and active in the formation of tumor in breast. Three active compounds Anthraquinone, Emodin and Kaempferol are evaluated using DFT calcul…
Symposium Report
Symposium ReportPublished: 11 Jun 2026
Pitchai Balakumar, Murugan Thangiah, Saravanan Pandiaraj, Shubhada Nagarkar, P. Ilangovan, P.K. Srividhya, R. Malliga, V. Ramachandran, V. Anburaj, Gowraganahalli Jagadeesh
pp. 1194-1201 · DOI: 10.5530/ijpi.20260003Vol. 16, Issue 3 (2026)It is imperative to address the complexities of conducting and disseminating high-quality research amidst a rapidly changing scientific environment in the era of Artificial Intelligence (AI). Despite the existence of ext…